Prostate cancer decisions — 2023

The Veteran's claims for bilateral hearing loss, tinnitus, hypertensive vascular disease, prostate cancer, cervical spine disorder (arthritis), and PTSD have been dismissed due to the Veteran withdrawing his appeals.,The Veteran's claim for secondary service connection for obstructive sleep apnea has been granted.

The Veteran's service connection claim for prostate cancer is denied as there was no exposure to herbicides or other chemicals during his active duty service, and the evidence does not support a finding that his prostate cancer is related to service.

The Veteran's appeal for service connection of prostate cancer, claimed as due to herbicide agent exposure, is dismissed because the Appellant died during the pendency of the appeal.

The Board has decided to remand the case due to insufficient medical evidence and a need for a VA examination to determine if the Veteran's prostate cancer is related to exposure to contaminated water at Camp Lejeune.

The Board has remanded the cases for additional development due to inadequate VA examinations. The Veteran's claims for service connection are pending and will be reconsidered.

The Board denied the Veteran's claim for a higher rating for prostate cancer, finding that the reduction from 100% to 10% was proper and that there were no residuals of prostate cancer warranting a higher rating.

The Board has remanded the Veteran's claim for prostate cancer service connection due to incomplete records and a need for further development, including obtaining additional medical records from Dr. G. in Klamath Falls.

The Board denied service connection for brain aneurysm, coronary artery disease (CAD), epilepsy secondary to brain aneurysm, hypertension, and prostate cancer. The Veteran's claims were not supported by evidence of in-service exposure or a link between the conditions and service.

The Board has remanded the claims of service connection for diabetes mellitus type II, prostate cancer, and skin cancer (including melanoma) due to herbicide exposure. The AOJ was directed to investigate the Veteran's assertions of herbicide exposure and issue a Formal Finding with a determination as to the likelihood of such exposure. VA examinations were also scheduled to determine if the claimed conditions began during service or are otherwise related to service.

The Veteran's heart disability and prostate cancer prevented him from securing or following a substantially gainful occupation, meeting the criteria for an extraschedular TDIU rating.

The Board has remanded the claims for prostate and bladder cancer residuals due to insufficient information regarding potential exposure to herbicide agents during service in Korea.

The Veteran's prostate cancer is granted service connection due to presumed exposure to herbicide agents during service at Korat RTAFB in Thailand. The Veteran's erectile dysfunction is remanded for further examination and determination of its relationship to his prostate cancer.

The Veteran's claims for service connection for ischemic heart disease, diabetes mellitus type II, prostate cancer, and erectile dysfunction were granted with an effective date of October 1, 1999.

The Board has reopened the claim for service connection for epididymitis and remanded the issue of service connection for prostate cancer. The Veteran's current epididymitis is presumed to have preexisted service, but it is unclear if it was aggravated by service.

The Board has remanded the Veteran's claims for service connection for various genitourinary and musculoskeletal disabilities, including prostate cancer, kidney disability, bladder disability, low back disability, right hip disability, bilateral shoulder disability, and right knee disability. The remand requires obtaining additional medical opinions to address the etiology of these conditions, particularly regarding exposure to contaminated water at Camp Lejeune.

The Board denied service connection for a recurrent left upper extremity disability, claimed as secondary to Parkinson's disease, finding that no such condition was shown during active service or at any time thereafter.

The Veteran's service-connected disabilities do not by themselves cause him to require aid and assistance in accomplishing the activities of daily living and render him unable to protect himself from the hazards and dangers of his daily environment. Therefore, SMC based on the need for aid and attendance is denied.

The Board has remanded the Veteran's claim for an increased rating for prostate cancer and whether the reduction from 100 percent was proper due to incomplete development. The Veteran is already service connected for nephropathy, which affects renal function.

The Veteran's prostate cancer residuals have been rated at 40 percent since September 10, 2015. The Board has determined that a higher rating is not warranted prior to June 16, 2022 and from November 13, 2022.,From June 16, 2022 to November 13, 2022, the Veteran's prostate cancer residuals have been rated at 60 percent.

The Veteran withdrew his appeal regarding the service connection for prostate cancer before a decision was made.